![tirzepatide hepatic impairment child-pugh classification for degree of dysfunction [11] Systemic Therapies for Hepatocellular Carcinoma](https://www.researchgate.net/publication/347966433/figure/tbl1/AS:973927811657728@1609213893183/Child-Pugh-classification-for-degree-of-hepatic-dysfunction-11.png)
tirzepatide hepatic impairment child-pugh classification for degree of dysfunction [11] Systemic Therapies for Hepatocellular Carcinoma
USD23.45
USD73.45
Pay in 4 interest-free payments of $5.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
![tirzepatide hepatic impairment child-pugh classification for degree of dysfunction [11] Systemic Therapies for Hepatocellular Carcinoma](https://dailynews.ascopubs.org/cms/asset/5246e958-4ef5-48c4-87e0-e6555aa2a3f1/dn22_ee_li_figure.png)
![tirzepatide hepatic impairment child-pugh classification for degree of dysfunction [11] Systemic Therapies for Hepatocellular Carcinoma](https://ars.els-cdn.com/content/image/1-s2.0-S1590865826002926-gr1.jpg)
![tirzepatide hepatic impairment child-pugh classification for degree of dysfunction [11] Systemic Therapies for Hepatocellular Carcinoma](https://cdn.psychopharmacologyinstitute.com/wp-content/uploads/2025/06/psychopharmacology-files/transcripts/%5B4005%5D+Rating+Scales+for+Hepatic+Dysfunction+Child-Pugh/image1.jpeg)
![tirzepatide hepatic impairment child-pugh classification for degree of dysfunction [11] Systemic Therapies for Hepatocellular Carcinoma](https://jodiettenberg.com/wp-content/uploads/2026/03/Mast-cell-activation-syndrome.jpg)
.png)
